Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization
- PMID: 16099912
- DOI: 10.1099/vir.0.81199-0
Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization
Abstract
Mannose-binding lectin (MBL), a serum lectin that mediates innate immune functions including activation of the lectin complement pathway, binds to carbohydrates expressed on some viral glycoproteins. In this study, the ability of MBL to bind to virus particles pseudotyped with Ebola and Marburg envelope glycoproteins was evaluated. Virus particles bearing either Ebola (Zaire strain) or Marburg (Musoke strain) envelope glycoproteins bound at significantly higher levels to immobilized MBL compared with virus particles pseudotyped with vesicular stomatitis virus glycoprotein or with no virus glycoprotein. As observed in previous studies, Ebola-pseudotyped virus bound to cells expressing the lectin DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin). However, pre-incubation of virus with MBL blocked DC-SIGN-mediated binding to cells, suggesting that the two lectins bind at the same or overlapping sites on the Ebola glycoprotein. Neutralization experiments showed that virus pseudotyped with Ebola or Marburg (Musoke) glycoprotein was neutralized by complement, while the Marburg (Ravn strain) glycoprotein-pseudotyped virus was less sensitive to neutralization. Neutralization was partially mediated through the lectin complement pathway, since a complement source deficient in MBL was significantly less effective at neutralizing viruses pseudotyped with filovirus glycoproteins and addition of purified MBL to the MBL-deficient complement increased neutralization. These experiments demonstrated that MBL binds to filovirus envelope glycoproteins resulting in important biological effects and suggest that MBL can interact with filoviruses during infection in humans.
Similar articles
-
Enhancement of Ebola Virus Infection via Ficolin-1 Interaction with the Mucin Domain of GP Glycoprotein.J Virol. 2016 May 12;90(11):5256-5269. doi: 10.1128/JVI.00232-16. Print 2016 Jun 1. J Virol. 2016. PMID: 26984723 Free PMC article.
-
Inhibition of DC-SIGN-mediated trans infection of T cells by mannose-binding lectin.Immunology. 2003 Sep;110(1):80-5. doi: 10.1046/j.1365-2567.2003.01707.x. Immunology. 2003. PMID: 12941144 Free PMC article.
-
Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors.PLoS One. 2013;8(4):e60838. doi: 10.1371/journal.pone.0060838. Epub 2013 Apr 2. PLoS One. 2013. PMID: 23573288 Free PMC article.
-
Mannose binding lectin (MBL) and HIV.Mol Immunol. 2005 Feb;42(2):145-52. doi: 10.1016/j.molimm.2004.06.015. Mol Immunol. 2005. PMID: 15488604 Review.
-
The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.Arch Virol Suppl. 1999;15:159-69. doi: 10.1007/978-3-7091-6425-9_11. Arch Virol Suppl. 1999. PMID: 10470276 Review.
Cited by
-
Limited effect of recombinant human mannose-binding lectin on the infection of novel influenza A (H7N9) virus in vitro.Biochem Biophys Res Commun. 2015 Feb 27;458(1):77-81. doi: 10.1016/j.bbrc.2015.01.070. Epub 2015 Jan 26. Biochem Biophys Res Commun. 2015. PMID: 25634695 Free PMC article.
-
Complement-mediated neutralization of dengue virus requires mannose-binding lectin.mBio. 2011 Dec 13;2(6):e00276-11. doi: 10.1128/mBio.00276-11. Print 2011. mBio. 2011. PMID: 22167226 Free PMC article.
-
Innate Immunity Mechanisms in Marine Multicellular Organisms.Mar Drugs. 2022 Aug 25;20(9):549. doi: 10.3390/md20090549. Mar Drugs. 2022. PMID: 36135738 Free PMC article. Review.
-
Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.Front Immunol. 2022 Apr 12;13:857481. doi: 10.3389/fimmu.2022.857481. eCollection 2022. Front Immunol. 2022. PMID: 35493467 Free PMC article.
-
Receptor mimicry as novel therapeutic treatment for biothreat agents.Bioeng Bugs. 2010 Jan-Feb;1(1):17-30. doi: 10.4161/bbug.1.1.10049. Bioeng Bugs. 2010. PMID: 21327124 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous